Researchers are increasingly interested in a new biomarker for Alzheimer's disease. Its name: TREM-2. This protein can be found in the cerebrospinal fluid several years…

A study published last November in Science magazine has changed our understanding of the molecular cascade that triggers Alzheimer's disease. A team from the New…

  Several pharmaceutical companies are currently developing drugs that target Alzheimer's disease. Developping a new drug takes years, and until now, no therapeutic has been…